Exposure of Anionic Phospholipids upon Platelet Activation Permits Binding of β2 Glycoprotein I and Through it that ofIgG Antiphospholipid Antibodies. Studies in Platelets from Patients with Antiphospholipid Syndrome and Normal Subjects

Journal of Autoimmunity

Volumn 7, Issue 3, 1994, Pages 335-348

  Vázquez Mellado, Janitzia ^a   Llorente, Luis ^a   Richaud Patin, Yvonne ^a   Alarcón Segovia, Donato ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

ANIONS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BLOOD PLATELETS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HUMAN; IMMUNOGLOBULIN G; MALE; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; PLATELET ACTIVATION; SUPPORT, NON-U.S. GOV'T;

EID: 0028216441     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1006/jaut.1994.1024     Document Type: Article

References (52)

1. Delezé, Mo C., V. Oria, and Alarcón-Segovia A. 1988, Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J. Rheumatol. 14: 611-615.
2. Hughes, G. R. V. 1985. The anticardiolipin syndrome. Clin. Exp. Rheumatol. 3: 285-286.
3. Harris, E. N., A. E. Gharavi, and G. R. V. Hughes. 1986. Antiphospholipid antibodies. Clin. Rheum. Dis. 11: 591-609.
4. Hughes, G. R. V., E. N. Harris, and A. E. Gharavi. 1986. The anticardiolipin syndrome. J. Rheumatol. 13: 486-489.
5. Alarcón-Segovia, D., M. Delezé, C. V. Oria, J. Sánchez-Guerrero, L. Gómez-Pacheco, J. Cabiedes, L. Fernández, and S. Ponce de León. 1989. Antiphospholipid antibodies and the antiphospholipid syndrome in Systemic Lupus Erythematosus. Medicine 68: 353-365.
6. Alarcón-Segovia, D. and J. Sánchez-Guerrero. 1989, Primary antiphospholipid syndrome. J. Rheumatol. 16: 482-488.
7. Harris, E. N., R. A. Asherson, A. E. Gharavi, S. H. Morgan, G. Deme, and G. R. V. Hughes. 1985. Thrombocytopenia in SLE and related autoimmune disorders: Association with anticardiolipin antibody. Br. J. Hematol. 59: 227-230.
8. Delezé, M., D. Alarcón-Segovia, C. V. Oria, J. Sánchez-Guerrero, L. Fernández Domínguez, L. Gómez-Pacheco, and S. Ponce de León. 1989. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J. Rheumatol 16: 926-930.
9. Alarcón-Segovia, D. 1988. Pathogenetic potential of antiphospholipid antibodies. J. Rheumatol. 15: 890-893.
10. Alarcón-Segovia, D. 1991. The pathophysiology of antiphospholipid antibodies. Sem. Clin. Immunol. 1: 11-19.
11. Pierangelli, S. S., E. Robinson, and E. N. Harris. 1989. Gold labelled affinity-purified anticardiolipin antibodies specifically bind human platelet membranes (abstract). Arthritis Rheum, (suppl.) 34: 122.
12. Rote, N. S., A. K. Ng, D. A. Dostal-Johnson, S. L. Nicholson, and R. Siekman. 1993. Immunologic detection of phosphatidylserine extemalization during thrombin-induced platelet activation. Clin. Immunol. Immunopathol. 66: 193-200.
13. Haga, H. J., C. Christopoulos, S. J. Machin, M. Khamashta, and G. R. V. Hughes. 1992. Lack of specific binding of anticardiolipin antibodies to intact platelets. Lupus 1: 387-900.
14. Out, H. J., P. G. de Groot, M. van Vliet, G. C. de Gast, K. Nieuwenhuis, and R. H. W. M. Derksen. 1991. Antibodies to platelets in patients with antiphospholipid antibodies. Blood 77: 2655-2659.
15. Rauch, J., Q. H. Meng, and H. Tannenbaum. 1987. Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies. J. Immunol. 139: 2598-2604.
16. Harris, E. N., A. E. Gharavi, S. Loizou, G. Derue, J. K. H. Chan, B. M. Patel, C. G. Mackworth Young, C. C. Bum, and G. R. V. Hughes. 1985. Crossreactivity of antiphospholipid antibodies. J. Clin. Lab. Immunol. 17: 155-162.
17. Pengo, V., P. Thiagarajan, S. S. Shapiro, and M. H. Heine. 1987. Immunological specificity and mechanisms of action of IgG lupus anticoagulants. Blood 70: 69-76.
18. McNeil, H. P., C. N. Chesterman, and S. A. Krillis. 1988. Binding specificity of lupus anticoagulants and anticardiolipin antibodies. Thromb. Res. 52: 609-619.
19. Zwaal, R. F. A., P. Comfurius, and L. L. M. van Deenen. 1977. Membrane asymmetry and blood coagulation. Nature 268: 358-360.
20. Bevers, E. M., P. Comfurius, and R. F. A. Zwaal. 1983. Changes in membrane phospholipid distribution during platelet activation. Biochem. Biophys. Acta 736: 57-66.
21. Bevers, E. M., P. Comfurius, and R. F. A. Zwaal. 1991. Platelet procoagulant activity: Physiological significance and mechanisms of exposure. Blood Reviews 5: 146-154.
22. Zwaal, R. F. A., P. Comfurius, and E. M. Bevers. 1992. Platelet procoagulant activity and micro vesicle formation. Its putative role in hemostasis and thrombosis. Biochem. Biophys., Acta 1180: 1-8.
23. McNeil, H. P., R. J. Simpson, C. N. Chesterman, and S. A. Krilis. 1990. Antiphospholipid antibodies are directed against a complex antigen that include a lipid binding inhibitor of coagulation: 02 glycoprotein I (apolipoprotein H). Proc. Nad. Acad. Sci. 87: 4120-4124.
24. Galli, M., P. Comfurius, C. Maasen, H. C. Hemker, M. H. de Baets, P. J. C. van Breda-Vriesman, T. Barbui, R. F. A. Zwaal, and E. M. Bevers. 1990. Anticardiolipin antibodies directed not to cardiolipin but to a plasma cofactor. Lancet 335: 1544-1547.
25. Schousboe, I. 1980. Binding of 02 glycoprotein I to platelets: Effect of adenylate cyclase activity. Thromb. Res. 19: 225-237.
26. Shi, W., B. H. Chong, and C. N. Chesterman. 1993. glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: Differences with lupus anticoagulants. Blood 81: 1255-1262.
27. Galli, M., E. M. Bevers, P. Comfurius, T. Barbui, and R. F. A. Zwaal. 1993. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet derived microvesicles. Br. J. Hematol. 83: 466-472.
28. McEver, R. P. and M. N. Martin. 1984. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J. Biol. Chem. 259: 9799.
29. Alarcôn-Segovia, D., M. E. Pérez-Vâzquez, A. R. Villa, C. Drenkard, and J. Cabiedes. 1992. Preliminary classification criteria for the antiphospholipid syndrome within Systemic lupus erythematosus. Sem. Arthritis Rheum, 21: 275-286.
30. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of Systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
31. McNeil, H. P., S. A. Krilis, and C. N. Chsterman. 1988. Purification of antiphospholipid antibodies using a new affinity method. Thromb. Res. 52: 641-648.
32. McNeil, H. P., C. N. Chesterman, and S. A. Krilis. 1989. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br. J. Hematol, 73: 506-513.
33. Johnstone, A. and R. Thorpe. 1982. In Immunochemistry in Practice 2nd edn. Blackwell Scientific Publications, UK. pp. 264-267.
34. Polz, E., H. Wurm, and G. H. Kostner. 1980. Investigations on 02 glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fractions. J. Biochem. 11: 265-270.
35. Day, J. R., P. J. O’Hara, F. J. Grant, C. Lofton-Day, M. N. Berkaw, P. Werner, and P. Amaud. 1992. Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (02 glycoprotein I). Int. J. Clin. Lab. Res. 21: 256-263.
36. McCrae, K. R., S. J. Shattil, and D. B. Cines. 1990. Platelet activation induces increased Fey receptor expression. J, Immunol. 144: 3920-3927.
37. Alarcon-Segovia, D. and A. R. Cabral. 1992. Functional and immunochemical heterogeneity of aPL: A classification. J. Rheumatol. 19: 1166-1169.
38. Ashby, B., J. L. Daniel, and J. B. Smith. 1990. Mechanisms of platelet activation and inhibition. Hematol-Oncol. Clin. North Am. 4: 1-23.
39. Charo, I. F., R. D. Feinman, and T. C. Detwiller. 1977. Interrelations of platelet aggregation and secretion. J. Clin. Invest. 60: 866-873.
40. George, J. N., R. M. Lyons, and R. K. Morgan. 1980. Membrane changes associated with platelet activation. J. Clin, Invest. 66: 1-9.
41. Johnston, G. I., E. B. Pickett, R. P. McEver, and J. N. George. 1987. Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood 69: 1401-1403.
42. Sims, P. J., T. Wiedmer, C. T. Esmon, H. J. Weiss, and S. J. Shattil. 1989. Assembly of the platelet prothrombinase complex is linked to vésiculation of the platelet plasma membrane, J, Biol. Chem, 264: 17049-17057.
43. Bevers, E. M., M. Galli, T. Barbui, P. Comfurius, and R. F. A. Zwaal. 1991. Lupus anticoagulant IgG(s) (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 66: 629-632.
44. Harris, E. N. 1985. Crossreactivity of antiphospholipid antibodies. J. Clin. Lab. Immunol. 16: 1-6.
45. Cabral, A. R., J. Cabiedes, D. Alarcon-Segovia, and J. Sanchez-Guerrero. 1992. Phospholipid specificity and requirement of 02 glycoprotein I for reactivity of antibodies from patients with Primary Antiphospholipid syndrome. J. Autoimmunity 5: 787-801.
46. Kieffer, N. and D. R. Phillips. 1990. Platelet membrane glycoproteins: functions in cellular interactions. Ann. Reu Cell. Biol. 6: 329-357.
47. McEver, R. P. 1990. The clinical significance of platelet membrane glycoproteins. Hematol. Oncol. Clin, North Am. 4: 47-105.
48. Viard, J. P., M. D. Zahir-Amoura, and J. F. Bach. 1992. Association of anti-02 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in Systemic lupus erythematosus. Am. J. Med. 93: 181-186.
49. Cabral, A. R., M. Rodriguez, J. Cabiedes, and D. Alarcon-Segovia. 1993. Antibodies to 02 glycoprotein I associate with antiphospholipid syndrome whether primary (PAPS) or secondary to systemic lupus erythematosus (abstract). Arthritis Rheum. 36: (suppl.) S242.
50. Matsuura, E., Y. Igarashi, M. Fujimoto, K. Ichikawa, T. Suzuki, T. Yasuda, and T. Koike. 1992. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 148: 3885-3891.
51. Rauch, J. and A. S. Janoff. 1992. The nature of anti-phospholipid antibodies. J. Rheumatol. 19: 1782-1785.
52. Alarcon-Segovia, D. and A. R. Cabral. 1994. Antiphospholipid antibodies: Where do they come from? where do they go to? J. Rheumatol, (in press).